RANITIDINE

Manufacturer
WOCKHARDT LIMITED
Effective date
2011-11-15
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:30:10

Label at a glance#

ProductRANITIDINE
Active ingredientRANITIDINE HYDROCHLORIDE
Label structure14 sections

Indications and uses

relieves heartburn associated with acid indigestion and sour stomach prevents heartburn associated with acid indigestion and sour stomach brought on by certain foods and beverages

Dosage and administration

adults and children 12 years and over: to relieve symptoms, swallow 1 tablet with a glass of water to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn can be used up to twice daily (do not take more than 2 tablets in 24 hours) children under 12 years: ask a doctor

Label contents#

Full prescribing information#

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Ranitidine 150 mg (as ranitidine hydrochloride 168 mg)

Purpose

OTC - PURPOSE SECTION

Acid reducer

Uses

INDICATIONS & USAGE SECTION

  • relieves heartburn associated with acid indigestion and sour stomach
  • prevents heartburn associated with acid indigestion and sour stomach brought on by certain foods and beverages

Warnings

WARNINGS SECTION

Allergy alert: Do not use if you are allergic to ranitidine or other acid reducers

Do not use

OTC - DO NOT USE SECTION

  • if you have trouble or pain swallowing food, vomiting with blood, or bloody  or black stools. These may be signs of a serious condition. See your doctor.
  • with other acid reducers
  • if you have kidney disease, except under the advice and supervision of a doctor

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

  • frequent chest pain     
  • frequent wheezing, particularly with heartburn      
  • unexplained weight loss   
  • nausea or vomiting      
  • stomach pain
  • had heartburn over 3 months. This may be a sign of a more serious condition.
  • heartburn with lightheadedness, sweating or dizziness
  • chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • your heartburn continues or worsens
  • you need to take this product for more than 14 days

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • adults and children 12 years and over:
    • to relieve symptoms, swallow 1 tablet with a glass of water
    • to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn
    • can be used up to twice daily (do not take more than 2 tablets in 24 hours)
  • children under 12 years: ask a doctor

Other information

SPL UNCLASSIFIED SECTION

  • Blister: do not use if individual unit is open or torn 
    Bottle: do not use if printed foil under bottle cap is open or torn
  • store at 20°-25°C (68°-77°F)
  • avoid excessive heat or humidity
  • this product is sugar free

Inactive Ingredients

INACTIVE INGREDIENT SECTION

colloidal silicon dioxide, croscarmellose sodium, diethyl phthalate, FD and C yellow # 6 aluminum lake, hypromellose, iron oxide red, magnesium stearate, microcrystalline cellulose and titanium dioxide.

OTC - QUESTIONS SECTION

Questions or comments?
Call 1-800-346-6854

Read the directions, consumer information leaflet and warnings before use. Keep the carton. It contains important information.

Manufactured by:
Wockhardt Limited,
Mumbai, India.

Distributed by:
Wockhardt USA LLC.
20 Waterview Blvd.
Parsippany, NJ 07054
USA.

Rev.151111

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

500 T Label
500 T Label

500 T Carton
500 T Carton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
198191ranitidine 150 MG Oral TabletPSN1
198191ranitidine 150 MG Oral TabletSCD1
198191ranitidine 150 MG (as ranitidine HCl 168 MG) Oral TabletSY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
RANITIDINE Pharmacologic Class Indexing3Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
7f54af34-be54-4c3c-894f-78df6452d747Product name320190703
ccf8541e-b7dc-e6ba-06c9-15bf143a7850Product name520190611
05700d9e-ea6f-4aab-b0ed-1488f1d85d7bProduct name120180904
2f9d4e5c-e179-490e-8c43-f19e1e0ca228Product name120160720

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
55648-741-00RANITIDINE30000 in 1 DRUMTABLET, COATED300001
55648-741-01RANITIDINE10 in 1 BOTTLETABLET, COATED101
55648-741-01RANITIDINE1 in 1 CARTONTABLET, COATED11
55648-741-02RANITIDINE100 in 1 BOTTLETABLET, COATED1001
55648-741-02RANITIDINE1 in 1 CARTONTABLET, COATED11
55648-741-03RANITIDINE10 in 1 BLISTER PACKTABLET, COATED101
55648-741-03RANITIDINE10 in 1 CARTONTABLET, COATED101
55648-741-05RANITIDINE1 in 1 CARTONTABLET, COATED11
55648-741-05RANITIDINE500 in 1 BOTTLETABLET, COATED5001
55648-741-06RANITIDINE6000 in 1 POUCHTABLET, COATED60001

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
55648-741RANITIDINE TABLET, COATED [WOCKHARDT LIMITED]1Legacy NDC, 10 package rows20111118_d6cfdf6c-9b09-440e-81a4-04d45d247751.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
RANITIDINE HYDROCHLORIDEACTIVE INGREDIENTBK76465IHM1
RANITIDINEACTIVE MOIETY884KT10YB71
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61U1
COLLOIDAL SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU41
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH481
DIETHYL PHTHALATEINACTIVE INGREDIENTUF064M00AF1
FD&C YELLOW NO. 6INACTIVE INGREDIENTH77VEI93A81
FERRIC OXIDE REDINACTIVE INGREDIENT1K09F3G6751
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WO1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I301
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JP1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
55648-74155648-741-01, 55648-741-02, 55648-741-05, 55648-741-03, 55648-741-06, 55648-741-00

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 5 · 269 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOSOLUTION / OPHTHALMIC0.5 %w/vExact identifier — unii candidate
27 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORALNAExact identifier — unii candidate
49 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4CREAM / VAGINAL51 mgExact identifier — unii candidate
49 equally ranked IID candidates
FD&C YELLOW NO. 6FD&C YELLOW NO. 6H77VEI93A8CAPSULE / ORAL7 mgExact identifier — unii candidate
34 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, FOR SUSPENSION / ORAL131 mgExact identifier — unii candidate
39 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4GRANULE, DELAYED RELEASE / ORAL3.2 mgExact identifier — unii candidate
49 equally ranked IID candidates
DIETHYL PHTHALATEDIETHYL PHTHALATEUF064M00AFTABLET, EXTENDED RELEASE / ORAL43 mgExact identifier — unii candidate
9 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30WAFER / ORAL66 mgExact identifier — unii candidate
39 equally ranked IID candidates
FD&C YELLOW NO. 6FD&C YELLOW NO. 6H77VEI93A8LOTION / TOPICALNAExact identifier — unii candidate
34 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UTABLET / ORAL6184 mgExact identifier — unii candidate
28 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET, CHEWABLE, EXTENDED RELEASE / ORAL2 mgExact identifier — unii candidate
49 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPSUSPENSION / ORAL113 mgExact identifier — unii candidate
40 equally ranked IID candidates
DIETHYL PHTHALATEDIETHYL PHTHALATEUF064M00AFTABLET, CHEWABLE / ORAL6 mgExact identifier — unii candidate
9 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPCREAM / TOPICAL80 mgExact identifier — unii candidate
40 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48CAPSULE / ORAL257 mgExact identifier — unii candidate
22 equally ranked IID candidates
FD&C YELLOW NO. 6FD&C YELLOW NO. 6H77VEI93A8TABLET / SUBLINGUAL1 mgExact identifier — unii candidate
34 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30IMPLANT / INTRAVITREALNAExact identifier — unii candidate
39 equally ranked IID candidates
DIETHYL PHTHALATEDIETHYL PHTHALATEUF064M00AFCAPSULE, COATED PELLETS / ORAL6.8 mgExact identifier — unii candidate
9 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4SYSTEM / TRANSDERMAL35 mgExact identifier — unii candidate
49 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET / BUCCAL17.5 mgExact identifier — unii candidate
39 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UGRANULE / ORAL29520 mgExact identifier — unii candidate
28 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPTABLET, FILM COATED, EXTENDED RELEASE / ORAL11 mgExact identifier — unii candidate
40 equally ranked IID candidates
FD&C YELLOW NO. 6FD&C YELLOW NO. 6H77VEI93A8TABLET, CHEWABLE / ORAL0.41 mgExact identifier — unii candidate
34 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UPOWDER, FOR SUSPENSION / ORAL4441 mgExact identifier — unii candidate
28 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4GRANULE, FOR SUSPENSION / ORAL200 mgExact identifier — unii candidate
49 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4POWDER, FOR SUSPENSION / ORAL2553 mgExact identifier — unii candidate
49 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UGRANULE, DELAYED RELEASE / ORAL789.6 mgExact identifier — unii candidate
28 equally ranked IID candidates
FD&C YELLOW NO. 6FD&C YELLOW NO. 6H77VEI93A8FILM / SUBLINGUAL0.03 mgExact identifier — unii candidate
34 equally ranked IID candidates
FD&C YELLOW NO. 6FD&C YELLOW NO. 6H77VEI93A8POWDER, FOR SUSPENSION / ORAL6 mgExact identifier — unii candidate
34 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4SOLUTION / ORAL336 mgExact identifier — unii candidate
49 equally ranked IID candidates
FD&C YELLOW NO. 6FD&C YELLOW NO. 6H77VEI93A8TABLET / BUCCAL1 mgExact identifier — unii candidate
34 equally ranked IID candidates
FD&C YELLOW NO. 6FD&C YELLOW NO. 6H77VEI93A8POWDER, FOR SOLUTION / ORAL40 mgExact identifier — unii candidate
34 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48CAPSULE, DELAYED RELEASE / ORAL72 mgExact identifier — unii candidate
22 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48INJECTION / INTRAMUSCULAR1 %w/vExact identifier — unii candidate
22 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOTABLET, ORALLY DISINTEGRATING / ORAL41 mgExact identifier — unii candidate
27 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675POWDER, FOR SUSPENSION / ORAL1 mgExact identifier — unii candidate
21 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4GRANULE, FOR SOLUTION / ORAL1.8 mg/120mlExact identifier — unii candidate
49 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, DELAYED RELEASE / ORAL144 mgExact identifier — unii candidate
39 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPDROPS / ORALNAExact identifier — unii candidate
40 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, CHEWABLE / ORAL127 mgExact identifier — unii candidate
39 equally ranked IID candidates
DIETHYL PHTHALATEDIETHYL PHTHALATEUF064M00AFTABLET / ORAL6 mgExact identifier — unii candidate
9 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4FILM, EXTENDED RELEASE / TRANSDERMAL49 mgExact identifier — unii candidate
49 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30INHALANT / ORAL0.08 mgExact identifier — unii candidate
39 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4CAPSULE, LIQUID FILLED / ORAL106 mgExact identifier — unii candidate
49 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48TABLET, ORALLY DISINTEGRATING / ORAL184 mgExact identifier — unii candidate
22 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61USUSPENSION, EXTENDED RELEASE / ORAL1120 mgExact identifier — unii candidate
28 equally ranked IID candidates
FD&C YELLOW NO. 6FD&C YELLOW NO. 6H77VEI93A8CAPSULE, LIQUID FILLED / ORAL1 mgExact identifier — unii candidate
34 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675CAPSULE, COATED PELLETS / ORAL2 mgExact identifier — unii candidate
21 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48TABLET, EXTENDED RELEASE / ORAL392 mgExact identifier — unii candidate
22 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOCAPSULE, DELAYED RELEASE / ORAL105 mgExact identifier — unii candidate
27 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48TABLET, FILM COATED / ORAL330 mgExact identifier — unii candidate
22 equally ranked IID candidates
FD&C YELLOW NO. 6FD&C YELLOW NO. 6H77VEI93A8POWDER / ORAL20 mgExact identifier — unii candidate
34 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOTABLET, CHEWABLE / ORAL11.8 mgExact identifier — unii candidate
27 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOGRANULE, FOR SUSPENSION / ORAL1.7 mgExact identifier — unii candidate
27 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4SUSPENSION, EXTENDED RELEASE / ORAL70 mgExact identifier — unii candidate
49 equally ranked IID candidates
FD&C YELLOW NO. 6FD&C YELLOW NO. 6H77VEI93A8DROPS / ORAL0.2 mg/1mlExact identifier — unii candidate
34 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TROCHE / ORAL315 mgExact identifier — unii candidate
39 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30PELLET / ORAL24 mgExact identifier — unii candidate
39 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPSUPPOSITORY / VAGINALNAExact identifier — unii candidate
40 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPTABLET, DELAYED RELEASE / ORAL66 mgExact identifier — unii candidate
40 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A078653-001RANITIDINE HYDROCHLORIDERANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-26

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-2684e616aacf4f…
2026-08-18 06:07:402026-07A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-26caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-26011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-2631067a03dcf5…
2025-08-23 18:47 UTC2025-08A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-266a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-26fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-26b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-2603ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-262680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-265bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-26d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-26d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-2679d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-26301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-261e350fbaab3a…
2024-05-31 18:47 UTC2024-05A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-268072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-265c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-265d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-264b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-2674a2ff9319b5…
2022-03-09 01:35 UTC2022-03A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-26bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-26782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-2687673890dc5c…
2021-03-12 10:30 UTC2021-03A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-265aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-268869cabd3fbd…
2020-11-12 02:37 UTC2020-11A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-26c0c555d07b60…
2019-12-14 00:12 UTC2019-12A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-263f01610625f2…
2019-09-15 20:21 UTC2019-09A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-26b00525d2431f…
2019-07-19 19:46 UTC2019-07A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-26ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-266a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-261c564ffb4f44…
2023-12-20 04:57 UTC2023-12A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-26ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-26a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-269b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-26a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-263f0d92c62455…
2023-05-13 08:27 UTC2023-05A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-26053a50430f4f…
2023-01-26 05:58 UTC2023-01A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-263bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-263a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A078653-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2007-11-26f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
e0f509b6-6e58-4f2d-8abf-84d4852cf9a2d6cfdf6c-9b09-440e-81a4-04d45d2477512011-11-15WarningsExact identifier
spl id: e0f509b6-6e58-4f2d-8abf-84d4852cf9a2
spl set id: d6cfdf6c-9b09-440e-81a4-04d45d247751

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.